Company Catabasis Pharmaceuticals Inc Nasdaq
Equities
US14875P1075
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jill Milne
FOU | Founder | 56 | 25/06/08 |
Noah Clauser
DFI | Director of Finance/CFO | 51 | 31/03/11 |
Chief Tech/Sci/R&D Officer | 54 | 14/07/22 | |
John Ruesch
PRN | Corporate Officer/Principal | - | 16/07/23 |
Keri McGrail
HRO | Human Resources Officer | - | 28/02/21 |
Andrew Komjathy
PRN | Corporate Officer/Principal | 61 | 24/09/19 |
Ben Harshbarger
LAW | General Counsel | 55 | 11/06/20 |
Andrea Matthews
PRN | Corporate Officer/Principal | 42 | 30/06/14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 31/12/13 |
Gregg Lapointe
BRD | Director/Board Member | 65 | 03/01/19 |
Director/Board Member | 75 | 04/04/16 | |
Jonathan Violin
BRD | Director/Board Member | 48 | 27/01/21 |
Jill Milne
FOU | Founder | 56 | 25/06/08 |
Sunil Agarwal
BRD | Director/Board Member | 54 | 04-07 |
Hugh Cole
BRD | Director/Board Member | 59 | 25/07/19 |
Joanne Beck
BRD | Director/Board Member | 63 | 13/02/19 |
Director/Board Member | 56 | 27/01/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,913,061 | 48,159,943 ( 87.70 %) | 0 | 87.70 % |
Stock B | 0 | 31,107 | 0 | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+16.61% | 121B | |
+17.75% | 110B | |
+17.23% | 25.98B | |
-24.11% | 19.27B | |
-18.56% | 15.99B | |
-18.47% | 15.66B | |
-47.75% | 14.5B | |
+57.35% | 14.47B | |
+5.62% | 13.91B |